Spok (SPOK) Expected to Announce Quarterly Earnings on Wednesday

Spok (NASDAQ:SPOK - Get Free Report) is anticipated to release its Q2 2025 earnings data before the market opens on Wednesday, July 23rd. Analysts expect Spok to post earnings of $0.18 per share and revenue of $35.00 million for the quarter. Spok has set its FY 2025 guidance at EPS.

Spok (NASDAQ:SPOK - Get Free Report) last issued its earnings results on Wednesday, April 30th. The Wireless communications provider reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.07. The business had revenue of $36.29 million for the quarter, compared to the consensus estimate of $34.00 million. Spok had a net margin of 11.45% and a return on equity of 10.26%. On average, analysts expect Spok to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Spok Trading Down 0.8%

Shares of NASDAQ:SPOK traded down $0.15 during midday trading on Thursday, hitting $17.75. The stock had a trading volume of 32,610 shares, compared to its average volume of 125,896. The company has a market capitalization of $365.14 million, a PE ratio of 22.77 and a beta of 0.58. The stock has a 50 day moving average price of $16.85 and a two-hundred day moving average price of $16.31. Spok has a 1 year low of $13.55 and a 1 year high of $18.29.

Spok Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Friday, May 23rd were issued a $0.3125 dividend. This represents a $1.25 annualized dividend and a dividend yield of 7.04%. The ex-dividend date of this dividend was Friday, May 23rd. Spok's payout ratio is 160.26%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on SPOK shares. Wall Street Zen raised shares of Spok from a "buy" rating to a "strong-buy" rating in a research report on Saturday, May 10th. B. Riley raised shares of Spok to a "strong-buy" rating in a report on Thursday, May 1st.

Insider Activity

In other news, COO Michael W. Wallace sold 6,000 shares of the firm's stock in a transaction dated Wednesday, May 7th. The shares were sold at an average price of $16.53, for a total transaction of $99,180.00. Following the completion of the transaction, the chief operating officer owned 61,175 shares in the company, valued at approximately $1,011,222.75. This trade represents a 8.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Vincent D. Kelly sold 30,000 shares of the firm's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $16.40, for a total transaction of $492,000.00. Following the transaction, the chief executive officer owned 157,817 shares of the company's stock, valued at approximately $2,588,198.80. This trade represents a 15.97% decrease in their position. The disclosure for this sale can be found here. Company insiders own 7.37% of the company's stock.

Institutional Trading of Spok

Hedge funds have recently made changes to their positions in the stock. AQR Capital Management LLC acquired a new position in Spok during the first quarter valued at approximately $271,000. Jane Street Group LLC acquired a new position in Spok during the first quarter valued at approximately $467,000. Finally, Goldman Sachs Group Inc. grew its stake in shares of Spok by 33.4% in the first quarter. Goldman Sachs Group Inc. now owns 521,571 shares of the Wireless communications provider's stock worth $8,575,000 after acquiring an additional 130,478 shares during the last quarter. 50.81% of the stock is owned by hedge funds and other institutional investors.

About Spok

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.